Huang et al. have discovered that EVs from atorvastatin-pretreated MSC (MSC-ATV-EVs) ameliorated cardiac dysfunction and reduced infarct area by diminishing IL-6 and TNF-α levels, promoting angiogenesis, and preventing apoptosis following MI. The gene discussed is TNF; the disease is myocardial infarction.